Capstone Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.8M | Buy |
44,400
+5,300
| +14% | +$2.88M | 0.04% | 160 |
|
|
2025
Q4 | $22.7M | Sell |
39,100
-14,300
| -27% | -$8.09M | 0.04% | 163 |
|
|
2025
Q3 | $25.9M | Buy |
53,400
+20,600
| +63% | +$9.59M | 0.05% | 170 |
|
|
2025
Q2 | $13.3M | Sell |
32,800
-1,800
| -5% | -$753K | 0.03% | 198 |
|
|
2025
Q1 | $17.2M | Sell |
34,600
-46,100
| -57% | -$25M | 0.05% | 199 |
|
|
2024
Q4 | $42M | Buy |
80,700
+19,200
| +31% | +$10.6M | 0.1% | 113 |
|
|
2024
Q3 | $38M | Buy |
61,500
+1,800
| +3% | +$1.07M | 0.12% | 115 |
|
|
2024
Q2 | $33M | Buy |
59,700
+7,700
| +15% | +$4.41M | 0.1% | 126 |
|
|
2024
Q1 | $30.2M | Sell |
52,000
-33,800
| -39% | -$19M | 0.11% | 129 |
|
|
2023
Q4 | $45.5M | Buy |
85,800
+25,700
| +43% | +$12.4M | 0.14% | 107 |
|
|
2023
Q3 | $30.4M | Buy |
60,100
+200
| +0.3% | +$107K | 0.14% | 101 |
|
|
2023
Q2 | $31.3M | Buy |
59,900
+3,200
| +6% | +$1.73M | 0.15% | 86 |
|
|
2023
Q1 | $32.7M | Buy |
56,700
+22,300
| +65% | +$12.6M | 0.17% | 72 |
|
|
2022
Q4 | $18.9M | Sell |
34,400
-6,300
| -15% | -$3.34M | 0.14% | 113 |
|
|
2022
Q3 | $20.6M | Sell |
40,700
-10,300
| -20% | -$5.76M | 0.12% | 99 |
|
|
2022
Q2 | $27.7M | Sell |
51,000
-129,500
| -72% | -$71.3M | 0.14% | 91 |
|
|
2022
Q1 | $107M | Sell |
180,500
-332,100
| -65% | -$191M | 0.29% | 37 |
|
|
2021
Q4 | $342M | Buy |
512,600
+78,500
| +18% | +$49M | 0.57% | 24 |
|
|
2021
Q3 | $248M | Buy |
434,100
+105,100
| +32% | +$57.7M | 0.49% | 31 |
|
|
2021
Q2 | $166M | Buy |
329,000
+66,200
| +25% | +$31.2M | 0.38% | 49 |
|
|
2021
Q1 | $120M | Buy |
262,800
+200
| +0.1% | +$95.5K | 0.35% | 55 |
|
|
2020
Q4 | $122M | Buy |
262,600
+89,400
| +52% | +$41.9M | 0.41% | 39 |
|
|
2020
Q3 | $76.5M | Buy |
173,200
+18,100
| +12% | +$7.48M | 0.39% | 38 |
|
|
2020
Q2 | $56.2M | Buy |
155,100
+81,100
| +110% | +$27.2M | 0.37% | 37 |
|
|
2020
Q1 | $21M | Sell |
74,000
-77,900
| -51% | -$24.6M | 0.34% | 49 |
|
|
2019
Q4 | $49.3M | Buy |
151,900
+3,900
| +3% | +$1.18M | 0.27% | 79 |
|
|
2019
Q3 | $43.1M | Buy |
148,000
+51,100
| +53% | +$14.6M | 0.3% | 69 |
|
|
2019
Q2 | $28.5M | Buy |
96,900
+45,200
| +87% | +$12.4M | 0.21% | 109 |
|
|
2019
Q1 | $14.2M | Buy |
51,700
+38,100
| +280% | +$9.48M | 0.13% | 164 |
|
|
2018
Q4 | $3.04M | Buy |
13,600
+1,600
| +13% | +$375K | 0.04% | 355 |
|
|
2018
Q3 | $2.93M | Buy |
12,000
+1,200
| +11% | +$276K | 0.03% | 355 |
|
|
2018
Q2 | $2.24M | Buy |
+10,800
| New | +$2.29M | 0.03% | 263 |
|
|
2017
Q1 | – | Sell |
-1,500
| Closed | -$211K | – | 1122 |
|
|
2016
Q4 | $211K | Buy |
+1,500
| New | +$221K | 0.01% | 810 |
|
Other funds holding TMO
VCM
Capstone Investment Advisors's TMO Position: Q1 2026 in Review
Capstone Investment Advisors increased its Thermo Fisher Scientific (TMO) stake by 50% in Q1 2026, buying an estimated $404K and bringing the position to 2,235 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #837.
Capstone Investment Advisors first reported a position in TMO in Q2 2014 and has held it in 32 quarters since. The position peaked at $15M in Q1 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Capstone Investment Advisors held 2,235 shares of Thermo Fisher Scientific worth $1.1M as of Q1 2026.
- Capstone Investment Advisors bought 744 Thermo Fisher Scientific shares in Q1 2026, an estimated $404K.
- Thermo Fisher Scientific made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #837 holding.
- Capstone Investment Advisors first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 32 quarters since.
- Capstone Investment Advisors's Thermo Fisher Scientific position peaked at $15M in Q1 2021.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.